Taiwania Capital

Type

Venture Capital

Status

Active

Location

Taipei, Taiwan

Total investments

101

Average round size

17M

Portfolio companies

61

Rounds per year

14.43

Lead investments

18

Follow on index

0.40

Exits

4

Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceMachine LearningHealth CareManufacturingMedical DeviceMedicalHardware

Summary

The leading representative office of defined VC is situated in the Taipei. The fund was located in Asia if to be more exact in Taiwan.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Taiwania Capital, startups are often financed by Tyche Partners, R7 Partners, Latterell Venture Partners. The meaningful sponsors for the fund in investment in the same round are Tyche Partners, Korea Investment Partners, Kleiner Perkins. In the next rounds fund is usually obtained by RTW Investments LLC, Polaris Founders Capital, Perceptive Advisors.

We also calculated 7 valuable employees in our database.

The top activity for fund was in 2019. Opposing the other organizations, this Taiwania Capital works on 12 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this VC is 63 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019.

Among the most popular portfolio startups of the fund, we may highlight AEye, Pavilion Data Systems, Viracta Therapeutics. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Show more

Investor highlights

Industry focus
Biotech/Life Sciences
Stage focus
Series ASeries BSeed
Geo focus
TaiwanUnited States

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 150000000

Analytics

Total investments
101
Lead investments
18
Exits
4
Rounds per year
14.43
Follow on index
0.40
Investments by industry
  • Health Care (27)
  • Software (25)
  • Biotechnology (22)
  • Manufacturing (21)
  • Artificial Intelligence (16)
  • Show 90 more
Investments by region
  • United States (64)
  • Taiwan (22)
  • United Kingdom (3)
  • Slovakia (2)
  • Switzerland (2)
  • Show 3 more
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
1M
Group Appearance index
0.52
Avg. company exit year
13

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ethernovia 15 May 2023 Software, Autonomous Vehicles, Information and Communications Technology (ICT), Network Hardware Early Stage Venture 64M United States, California, San Jose
Oxipit 19 Jan 2023 B2B, Artificial Intelligence, Machine Learning, Health Care, Health Diagnostics, Computer Vision Early Stage Venture 4M Vilnius County, Vilnius, Lithuania
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.